focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

Share Price Information for Deltex Medical (DEMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.115
Bid: 0.11
Ask: 0.12
Change: 0.00 (0.00%)
Spread: 0.01 (9.091%)
Open: 0.115
High: 0.115
Low: 0.115
Prev. Close: 0.115
DEMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

17 Dec 2013 09:55

RNS Number : 7264V
Deltex Medical Group PLC
17 December 2013
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Deltex Medical Group PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

BlackRock, Inc.

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

12th December 2013

6. Date on which issuer notified:

16th December 2013

7. Threshold(s) that is/are crossed orreached: vi, vii

Holding has gone below 5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0059337583

9,135,789

9,135,789

N/A

N/A

N/A

N/A

Below 5%

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

N/A

Below 5%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

BlackRock Investment Management (UK) Limited - N/A (Below 5%)

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

BlackRock Regulatory Threshold Reporting Team

14. Contact name:

Duncan Murray

15. Contact telephone number:

020 7743 3334

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEANAXFLPDFEF
Date   Source Headline
2nd Mar 20161:01 pmRNSHolding(s) in Company
25th Feb 201611:00 amRNSResult of General Meeting
23rd Feb 20167:00 amRNSResult of the Open Offer
8th Feb 20167:00 amRNSPosting of Circular
3rd Feb 20167:00 amRNSPlacing and issue of new convertible loan notes
27th Jan 20167:00 amRNSNew US platform programme account opened
27th Jan 20167:00 amRNSTrading Update
9th Dec 20157:00 amRNSTwo new US platform programme accounts opened
23rd Nov 20157:00 amRNSTwo new US platform programme accounts opened
20th Nov 20157:00 amRNSUS fluid variation study published by Premier
18th Nov 20157:00 amRNSOpen access e-learning courses launched
12th Nov 20157:00 amRNSNew US Platform Programme Account Opened
16th Sep 20157:00 amRNSInterim Results
9th Sep 20157:00 amRNSNew US platform programme account opened
21st Aug 201510:40 amRNSHolding(s) in Company
29th Jul 20157:00 amRNSFDA approves paediatric probes for launch in USA
28th Jul 20151:40 pmRNSAdditional Listing
14th Jul 20157:00 amRNSPre-close Trading Update
14th Jul 20157:00 amRNSCanadian tender won
1st Jul 20154:45 pmRNSDirector/PDMR Shareholding
30th Jun 20157:00 amRNSNew US platform programme account opened
24th Jun 20157:00 amRNSNew UK Government R&D funding secured
23rd Jun 20158:00 amRNSAdditional Listing
23rd Jun 20157:00 amRNSDeltex appoints new Group Finance Director
15th Jun 20157:00 amRNSGrant of options
12th Jun 20151:58 pmRNSHolding(s) in Company
9th Jun 20157:00 amRNSLeading US hospital improves surgical outcomes
2nd Jun 20157:00 amRNSBoard Changes
22nd May 201510:25 amRNSDirector Shareholding
12th May 20151:01 pmRNSResult of AGM
6th May 20158:00 amRNSDirectors' Shareholdings/Issue of equity
6th May 20157:02 amRNSFirst US 'remote training' account
6th May 20157:01 amRNSChairman's Statement to Annual General Meeting
24th Apr 20157:00 amRNSBoard Changes
22nd Apr 20157:00 amRNSNew US dedicated trainer account
20th Apr 201511:40 amRNSAdditional Listing
13th Apr 20153:10 pmRNSDirector Shareholding
1st Apr 20157:00 amRNSNew US dedicated trainer account
25th Mar 20152:53 pmRNSAdditional Listing
25th Mar 20157:00 amRNSBoard Change
18th Mar 20154:06 pmRNSHolding(s) in Company
18th Mar 20157:00 amRNSDirector/PDMR Shareholding
18th Mar 20157:00 amRNSDirector/PDMR Shareholding
17th Mar 20157:00 amRNSClinical study validates PPWA in CardioQ-ODM+
16th Mar 201510:06 amRNSDirector/PDMR Shareholding
11th Mar 20157:00 amRNSFinal Results
25th Feb 20157:02 amRNSNotice of Results
12th Feb 20157:00 amRNSDeltex renews lease on manufacturing facility
19th Jan 20157:00 amRNSDeltex Medical sign new exclusive deal with CASMED
15th Jan 20157:00 amRNSNew Dedicated Trainer Account Opened in USA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.